GlassScriptPhysician profile
Mark S Messana
NPI 1427619568
$7,900.36
in general payments reported to CMS, 2019-2025
16 companies · $48.20 in 2025
The $48.20 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,409 · 2020: $2,775 · 2021: $465 · 2022: $1,775 · 2023: $427 · 2025: $48.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $5,461.48 | 2019-2022 | |
| Smith+Nephew, INC. | $729.69 | 2020-2023 | Bone Anchors With Arthroscopic Delivery System |
| Organogenesis INC. | $467.00 | 2019-2023 | Puraply |
| Stryker Corporation | $321.55 | 2019-2023 | Ortholoc 2 Lapifuse |
| Convatec INC. | $260.30 | 2023 | |
| Integra Lifesciences Corporation | $151.56 | 2020 | |
| Paratek Pharmaceuticals, INC. | $126.81 | 2022 | |
| Acell, INC. | $111.36 | 2019 | |
| Triad Life Sciences INC. | $102.12 | 2022 | |
| Zimmer Biomet Holdings, INC. | $37.36 | 2020 | |
| Bioventus LLC | $31.81 | 2021 | |
| Ermi LLC | $26.20 | 2025 | |
| Treace Medical Concepts, INC. | $22.00 | 2025 | |
| Viiv Healthcare Company | $21.43 | 2020 | |
| Baudax Bio INC. | $17.69 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Messana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.